Article Details
Retrieved on: 2024-10-24 21:37:59
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses regulatory updates relevant to biopharma, highlighting the EPA's proposed delay for PFAS reporting, ECHA's proposed addition of chemicals to the SVHC list, and microRNA's discovery impacting gene regulation, aligning with the key concept and tags provided.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here